Cover Image
市場調查報告書

Beijing Tiantan Biological Products Co., Ltd.:產品平台分析

Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 306089
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Beijing Tiantan Biological Products Co., Ltd.:產品平台分析 Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年10月30日 內容資訊: 英文 21 Pages
簡介

Beijing Tiantan Biological Products Co., Ltd.是研究、開發、製造、販售病毒及細菌傳染病用疫苗的生物科技企業。

本報告提供Beijing Tiantan Biological Products Co., Ltd.的治療藥開發平台現狀及各開發階段的比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,彙整最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

Beijing Tiantan Biological Products Co., Ltd.的基本資料

Beijing Tiantan Biological Products Co., Ltd.概要

  • 主要資訊
  • 企業資料

Beijing Tiantan Biological Products Co., Ltd.:R&D概要

  • 主要的治療範圍

Beijing Tiantan Biological Products Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Beijing Tiantan Biological Products Co., Ltd.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Beijing Tiantan Biological Products Co., Ltd.:藥物簡介

Beijing Tiantan Biological Products Co., Ltd.:開發平台分析

  • 各分子類型

Beijing Tiantan Biological Products Co., Ltd.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07718CDB

Summary

Global Markets Direct's, 'Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Beijing Tiantan Biological Products Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Beijing Tiantan Biological Products Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Beijing Tiantan Biological Products Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Beijing Tiantan Biological Products Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Beijing Tiantan Biological Products Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Beijing Tiantan Biological Products Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Beijing Tiantan Biological Products Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Beijing Tiantan Biological Products Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Beijing Tiantan Biological Products Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Beijing Tiantan Biological Products Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Beijing Tiantan Biological Products Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Beijing Tiantan Biological Products Co., Ltd. Snapshot
    • Beijing Tiantan Biological Products Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Beijing Tiantan Biological Products Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline Products Glance
    • Beijing Tiantan Biological Products Co., Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Beijing Tiantan Biological Products Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Beijing Tiantan Biological Products Co., Ltd. - Drug Profiles
    • meningococcal polysaccharide [serotypes A, C, Y, W-135] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • poliomyelitis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • measles + mumps + rubella + varicella vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • meningococcal [serotypes A and C] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pertussis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline Analysis
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline Products by Molecule Type
  • Beijing Tiantan Biological Products Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Beijing Tiantan Biological Products Co., Ltd., Key Information
  • Beijing Tiantan Biological Products Co., Ltd., Key Facts
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Indication, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Stage of Development, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Combination Treatment Modalities in Pipeline, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Phase I, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Preclinical, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Molecule Type, 2015
  • Beijing Tiantan Biological Products Co., Ltd., Subsidiaries

List of Figures

  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Stage of Development, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
Back to Top